Investment firms select strategies and allocate capital using backtests — simulations of performance on historical data — but standard overfitting safeguards (like a single holdout split) are unreliable in this setting. Bailey, Borwein, López de Prado and Zhu propose a general framework to assess the probability of backtest overfitting (PBO): the probability that the strategy chosen as best in-sample will underperform the median of the alternatives out-of-sample. Their model-free, nonparametric implementation, combinatorially symmetric cross-validation (CSCV), produces reasonable PBO estimates across examples.
"Standard statistical techniques designed to prevent regression overfitting, such as holdout, tend to be unreliable and inaccurate in the context of investment backtests. We propose a general framework to assess the probability of backtest overfitting (PBO) … combinatorially symmetric cross-validation (CSCV)."
Where the deflated Sharpe ratio corrects a reported number for the number of trials, PBO tackles the harder, more honest question: given the whole set of configurations you searched, how likely is it that your "winner" is a fluke? CSCV's cleverness is using every block as both train and test across all symmetric partitions, which turns the noisy single-holdout into a distribution of in-sample-vs-out-of-sample rank agreements — and the resulting PBO and performance-degradation plots are unusually legible for a statistical diagnostic. It is the rigorous backbone of the same authors' polemical "pseudo-mathematics" essay. The practical limitation is shared with the deflated SR: it needs the full menu of trials, so a researcher who quietly discards configurations before applying CSCV understates their own overfitting.